Personalized Medicine Requires Personalized Measurement

February 23, 2018

The Otsuka and Noven successes from 2018 portend a new era of drug development, one in which treatment efficacy is established in the context of the patient's overall life and behavior. It is time for measurement science to follow and embrace the fact that how we measure outcomes will evolve from applying one solution to finding an empirical basis for a highly customized application of all of them, enabled by technology. Personalized medicine needs a more personalized approach to measurement. 

Previous Flipbook
An Executive Summary: Speed, Efficiency, and Accuracy in Site Contracts and Payments
An Executive Summary: Speed, Efficiency, and Accuracy in Site Contracts and Payments

Next Flipbook
Case Study: Merck Site Selection & Feasibility Technology
Case Study: Merck Site Selection & Feasibility Technology

Request a Genetics in Clinical Trials training session

What You'll Learn